Verinata Health Announces Agreement with Teva Pharmaceutical Industries in Collaboration with MOR Institute for Medical Data to Commercialize the verifi® Prenatal Test in Israel

REDWOOD CITY, Calif.-- Illumina, Inc. (NASDAQ: ILMN) today announced that Teva Pharmaceutical Industries Ltd. signed an exclusive agreement with Verinata Health, an Illumina company, for the commercialization of the verifi® non-invasive prenatal test1 in Israel. The MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi® prenatal test to customers [...]

Implant Sciences Sells 11 Quantum Sniffers for Critical Infrastructure Protection to Saudi Arabia

WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has won a contract for 11 Quantum Sniffer™ QS-H150 handheld explosives trace detectors (ETDs) from a customer in Saudi Arabia. The units will be deployed for critical infrastructure protection in [...]

IDBS and Vivenics introduce novel SaaS approach for Netherlands science park

London, UK, Boston, US and Oss, Netherlands, - IDBS, the global provider of innovative data management, analytics and modeling solutions, today announced a partnership with informatics firm Vivenics, which offers solutions for life sciences research and development (R&D) organizations. Together the companies have introduced a novel Software-as-a-Service (SaaS) approach for the Pivot Park science park [...]

Sartorius Postpones Sale of Industrial Weighing Division

Goettingen, 3 – Sartorius, a leading international laboratory and pharmaceutical equipment provider, postponed the planned divestiture of its Industrial Weighing Division for the time being. While this division has attracted the wide interest of a number of investors, their investment decisions are being impacted by the current uncertain economic environment. “Interest in this business is [...]

Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System

SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it declared conformity with the requirements of the IVD Directive on June 26, 2013 and has applied the CE mark for the MiSeqDx Cystic Fibrosis System. The company is finalizing plans to commercialize the product in a number of European countries that require CE marking. The [...]

Moisture-Free Cold Storage is Easy With the Scienceware® Secador® Refrigerator Ready Desiccator

What happens to materials that need to be kept cold and in a low humidity environment? Up until now a clumsy and unrefined contraption was often pieced together. The Scienceware® Secador® Refrigerator Ready Desiccator makes that a thing of the past. This new addition to the best-selling Secador® desiccator family is designed to fit, and [...]

Genetic Technologies Executes Settlement Agreement with Reproductive Genetics Institute, Inc

In compliance with ASX Continuous Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report it has now executed a Settlement and Release Agreement with Reproductive Genetics Institute, Inc. of Chicago, Illinois, USA. In late August 2012, GTG reported it had filed suit against Reproductive Genetics Institute, Inc. in the United States [...]

Analytik Jena Subsidiary Obtained Approval for two ELISA-based Tests for Detection and Differentiation of PRRSV

Jena, – AJ Roboscreen, an Analytik Jena company, recently obtained the approval for two new assays for screening of swine sera for PRRSV (porcine reproductive and respiratory syndrome virus) antibodies and for evaluation. The new ELISA-based tests differentiate into PRRSV Type I (Europe-Type) and Type II (North America-Type). The ELISA (Enzyme Linked Immunosorbent Assay) is [...]

CHMP recommends EU approval of Roche’s Subcutaneous Herceptin for HER2 positive breast cancer

Roche (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that the European Union’s Committee for Medicinal Products for Human Use (CHMP) has today recommended EU approval of a subcutaneous formulation of Herceptin® (trastuzumab) for the treatment of patients with HER2-positive breast cancer. Since Herceptin’s first approval in 1998 this targeted medicine has been used [...]

bioMérieux Receives AOAC Official Methods Approval for VIDAS® UP LPT & VIDAS® LMX, Delivering Fast, Sensitive Total Listeria Detection

Durham, NC -- bioMérieux, a world leader in the field of in vitro diagnostics, today received two First Action Official Methods of Analysis (OMA) approvals from AOAC INTERNATIONAL for innovative food safety testing methods: VIDAS® UP Listeria (LPT) and VIDAS Listeria monocytogenes xpress (LMX). This unprecedented AOAC Expert Review Panel (ERP) approval of two food [...]

Access IBO on Knowledge Center